Mogrify has developed a proprietary direct cellular conversion technology, which makes it possible to transform any mature human cell type into any other without going through a pluripotent stem cell- or progenitor cell-state.
Cambridge
Stem cells, Regenerative medicine, Drug, Big data, Biotechnology, Bioinformatics
💡 You’re a corporate or investor and looking for startups that are innovating in the same market as Mogrify? We’re happy to assist you with our Startup Sourcing service.
